| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 70.777 | 68.225 | 110.903 | 116.073 | 58.997 | 0 | 0 | 0 | 0 | 196.652 |
| Total Income - EUR | 88.146 | 68.672 | 110.940 | 116.401 | 62.709 | 0 | 0 | 0 | 0 | 217.769 |
| Total Expenses - EUR | 53.330 | 61.785 | 94.184 | 110.869 | 56.670 | 8.851 | 46.353 | 87.917 | 59.596 | 425.035 |
| Gross Profit/Loss - EUR | 34.816 | 6.888 | 16.756 | 5.532 | 6.039 | -8.851 | -46.353 | -87.917 | -59.596 | -207.266 |
| Net Profit/Loss - EUR | 32.172 | 6.201 | 15.646 | 4.368 | 5.215 | -8.851 | -46.353 | -87.917 | -59.596 | -207.266 |
| Employees | 3 | 3 | 6 | 4 | 3 | 1 | 3 | 2 | 2 | 5 |
Check the financial reports for the company - Edomed Relife S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.686 | 5.283 | 3.709 | 2.952 | 0 | 37.095 | 830.157 | 813.842 | 854.737 | 2.990.665 |
| Current Assets | 14.038 | 16.320 | 18.987 | 18.341 | 7.450 | 26.422 | 30.901 | 19.698 | 19.321 | 114.521 |
| Inventories | 11.811 | 11.741 | 11.891 | 1.600 | 0 | 0 | 0 | 0 | 0 | 5.992 |
| Receivables | 674 | 1.337 | 77 | 431 | 0 | 19.719 | 24.814 | 14.701 | 14.656 | 62.408 |
| Cash | 1.553 | 3.242 | 7.019 | 16.311 | 7.450 | 6.703 | 6.087 | 4.997 | 4.665 | 46.121 |
| Shareholders Funds | 316 | 6.514 | 22.050 | 21.285 | 5.374 | -3.238 | -49.519 | 193.768 | 133.585 | -74.428 |
| Social Capital | 90 | 89 | 88 | 86 | 126 | 465 | 455 | 331.814 | 330.808 | 328.959 |
| Debts | 19.279 | 17.800 | 3.311 | 2.629 | 2.076 | 66.755 | 910.577 | 639.772 | 740.473 | 3.192.265 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Edomed Relife S.r.l.